Jeff McLeroy

Jeff McLeroy, MD, currently serves as the Vice President of Drug Safety & Pharmacovigilance at Allogene Therapeutics, a position held since November 2024. Prior to this role, Jeff held various positions in clinical development and drug safety at Synthekine, Instil Bio, and Kite Pharma. Jeff's experience includes significant leadership roles in patient safety at Kite Pharma and safety science at Genentech. In the earlier stages of their career, Jeff was a Medical Oncologist/Hematologist at Kaiser Permanente, where specialization areas included lung cancer, head/neck cancer, and survivorship/preventive oncology. Additionally, Jeff contributed to academia as an Assistant Clinical Professor at UC Davis School of Medicine and served as Chief of Medical Oncology/Hematology at the VA Martinez Medical Center, where program expansion and patient care enhancement were major achievements. Educational credentials include a Doctor of Medicine degree from UC Davis School of Medicine and fellowship training in Hematology and Medical Oncology.